pubmed-article:16713606 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16713606 | lifeskim:mentions | umls-concept:C0026549 | lld:lifeskim |
pubmed-article:16713606 | lifeskim:mentions | umls-concept:C0017890 | lld:lifeskim |
pubmed-article:16713606 | lifeskim:mentions | umls-concept:C0079883 | lld:lifeskim |
pubmed-article:16713606 | lifeskim:mentions | umls-concept:C0002766 | lld:lifeskim |
pubmed-article:16713606 | lifeskim:mentions | umls-concept:C1704410 | lld:lifeskim |
pubmed-article:16713606 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
pubmed-article:16713606 | lifeskim:mentions | umls-concept:C0231491 | lld:lifeskim |
pubmed-article:16713606 | lifeskim:mentions | umls-concept:C0205197 | lld:lifeskim |
pubmed-article:16713606 | lifeskim:mentions | umls-concept:C1554080 | lld:lifeskim |
pubmed-article:16713606 | lifeskim:mentions | umls-concept:C1706198 | lld:lifeskim |
pubmed-article:16713606 | lifeskim:mentions | umls-concept:C0332120 | lld:lifeskim |
pubmed-article:16713606 | lifeskim:mentions | umls-concept:C0237686 | lld:lifeskim |
pubmed-article:16713606 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:16713606 | pubmed:dateCreated | 2006-7-21 | lld:pubmed |
pubmed-article:16713606 | pubmed:abstractText | N-methyl-D-aspartate (NMDA) receptors are widely involved in opioid tolerance. However, it is less clear whether NMDA receptor antagonists reverse already-established tolerance and whether the intensity of the nociceptive stimulus influences morphine tolerance. Three days after implantation of morphine or control pellets the effects of i.v. morphine and pre-administration of saline or (+)-HA966 (a glycine site-specific NMDA receptor antagonist), were studied on the C-fibre reflex elicited by a wide range of stimulus intensities. Morphine both increased the threshold and decreased the slope of the recruitment curve in the "non-tolerant" group of animals. In the "morphine-tolerant" group, the threshold did not change but the gain of the stimulus-response curve decreased. The expression of tolerance to morphine depended on the intensity of the stimulus, being maximal when threshold stimulus intensities were used but considerably less with supra-threshold stimulation. As expected, a single treatment with (+)-HA966, potentiated morphine antinociception in "non-tolerant" rats. However, in "morphine-tolerant" rats (+)-HA966 reversed established morphine tolerance and increased the antinociceptive effects of morphine. These results suggest that (+)-HA966 interfered with expression of morphine tolerance, and offered an encouraging therapeutic approach for pain management in opioid abusers. | lld:pubmed |
pubmed-article:16713606 | pubmed:language | eng | lld:pubmed |
pubmed-article:16713606 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16713606 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16713606 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16713606 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16713606 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16713606 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16713606 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16713606 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16713606 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16713606 | pubmed:month | Aug | lld:pubmed |
pubmed-article:16713606 | pubmed:issn | 0028-3908 | lld:pubmed |
pubmed-article:16713606 | pubmed:author | pubmed-author:BonnetFrancis... | lld:pubmed |
pubmed-article:16713606 | pubmed:author | pubmed-author:Le... | lld:pubmed |
pubmed-article:16713606 | pubmed:author | pubmed-author:AdamFrédéricF | lld:pubmed |
pubmed-article:16713606 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16713606 | pubmed:volume | 51 | lld:pubmed |
pubmed-article:16713606 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16713606 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16713606 | pubmed:pagination | 191-202 | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:meshHeading | pubmed-meshheading:16713606... | lld:pubmed |
pubmed-article:16713606 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16713606 | pubmed:articleTitle | Tolerance to morphine analgesia: evidence for stimulus intensity as a key factor and complete reversal by a glycine site-specific NMDA antagonist. | lld:pubmed |
pubmed-article:16713606 | pubmed:affiliation | Institut National de la Santé et de la Recherche Médicale (INSERM) U-713, 75013 Paris, France. | lld:pubmed |
pubmed-article:16713606 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16713606 | lld:pubmed |